The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 7,186,780 | 465,465 | SH | SOLE | NONE | 465,465 | 0 | 0 | ||
ABBVIE INC | COM | 00287Y109 | 13,537,778 | 90,821 | SH | SOLE | NONE | 90,821 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 2,828,464 | 15,971 | SH | SOLE | NONE | 15,971 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 24,206,878 | 49,238 | SH | SOLE | NONE | 49,238 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 12,917,725 | 190,752 | SH | SOLE | NONE | 190,752 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 6,139,697 | 87,848 | SH | SOLE | NONE | 87,848 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 6,942,583 | 78,465 | SH | SOLE | NONE | 78,465 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 350,220 | 25,452 | SH | SOLE | NONE | 25,452 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 1,353,242 | 6,905 | SH | SOLE | NONE | 6,905 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 615,202 | 41,261 | SH | SOLE | NONE | 41,261 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 14,069,046 | 26,193 | SH | SOLE | NONE | 26,193 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 163,692 | 95,170 | SH | SOLE | NONE | 95,170 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 2,166,944 | 41,600 | SH | SOLE | NONE | 41,600 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 33,891,140 | 329,200 | SH | SOLE | NONE | 329,200 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 5,062,500 | 45,000 | SH | SOLE | NONE | 45,000 | 0 | 0 | ||
NOVO-NORDISK A S | ADR | 670100205 | 62,003,983 | 681,812 | SH | SOLE | NONE | 681,812 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 1,734,000 | 100,000 | SH | SOLE | NONE | 100,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 1,873,831 | 112,340 | SH | SOLE | NONE | 112,340 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 10,675,789 | 914,023 | SH | SOLE | NONE | 914,023 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 6,929,178 | 57,162 | SH | SOLE | NONE | 57,162 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 10,856,776 | 51,175 | SH | SOLE | NONE | 51,175 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 1,067,513 | 2,109 | SH | SOLE | NONE | 2,109 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 623,134 | 45,253 | SH | SOLE | NONE | 45,253 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 1,965,534 | 38,555 | SH | SOLE | NONE | 38,555 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 6,368,510 | 18,314 | SH | SOLE | NONE | 18,314 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 4,246,231 | 383,580 | SH | SOLE | NONE | 383,580 | 0 | 0 | ||
WATERS CORP | COM | 941848103 | 780,127 | 2,845 | SH | SOLE | NONE | 2,845 | 0 | 0 |